Rare diseases
Investigational molecules
Locations
A Phase 2 Study of MZE782 Safety, Tolerability, and Efficacy in Adults with Phenylketonuria
The NetherlandsNon‑inferiority of fractional varicella zoster virus glycoprotein E vaccine (AS01B) versus recombinant varicella zoster virus glycoprotein E vaccine in adults with shingles
The NetherlandsLong‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy
The NetherlandsA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
The NetherlandsRinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer
The NetherlandsRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
The NetherlandsA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
The NetherlandsPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
The NetherlandsStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
The NetherlandsA Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia
The NetherlandsLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
The NetherlandsStudy of Rinatabart Sesutecan with glatiramer acetate in patients with advanced gastrointestinal cancers
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
